Surgery
"Promedon"Vantris VUR Treatment System
Vantris is the latest evolved version of injectable material. It was developed as a new synthetic injectable filler for the treatment of VUR (vesicoureteral reflux) in children, meeting the need for a biocompatible, non-absorbable synthetic injectable material with long-term effectiveness and no safety concerns.
Technical Advantages:
- Vantris particles are amorphous and highly deformable under compression, ensuring the flowability of the hydrogel.
- The substance can be extruded through a 22-gauge needle, making the injection more precise and easier.
- Vantris is composed of biocompatible materials, non-immunogenic and non-antigenic.
- Vantris is non-animal derived, significantly reducing the risk of allergic reactions.
- The PPC microparticles are negatively charged, preventing interaction with surrounding cells and tissues. This results in minimal fibrosis with a thickness of only 70 microns.
- Minimal inflammatory response.
- No calcification.